Mylinax - Novel Therapy for the Treatment of Multiple Sclerosis

Print

Serono's biotech research is centred on increasing understanding of naturally occurring proteins such as the immunomodulator interferon-beta.
 
Next»




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development